Source: Eur Respir J, 54 (1) 1802143; 10.1183/13993003.02143-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Anne Huiberts, Sanne M.H. Zweijpfenning, Lian J. Pennings, Martin J. Boeree, Jakko van Ingen, Cecile Magis-Escurra, Wouter Hoefsloot. Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease. Eur Respir J, 54 (1) 1802143; 10.1183/13993003.02143-2018

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis identification in patients with pulmonary tuberculosis Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis Year: 2021 Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 A small audio device may be alternative to hypertonic saline inhalation for sputum induction in patients with pulmonary tuberculosis Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 A cross-over study to compare the Lung Flute™ to hypertonic saline inhalation about the performance of inducing sputum for the diagnosis of pulmonary tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Perspectives on antibiotic treatment of NTM pulmonary disease Source: Eur Respir Monogr 2017; 75: 245-252 Year: 2017 Surgery in nontuberculous mycobacteria pulmonary disease Source: Breathe, 14 (4) 288; 10.1183/20734735.027218 Year: 2018 New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Source: Virtual Congress 2020 – German programme 2020 Year: 2020 Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Treatment of nontuberculous mycobacterial pulmonary diseases (fast-growing organisms): an interactive session Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Safety of intravenous amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Treatment of nontuberculous mycobacterial pulmonary diseases (slow-growing organisms): an interactive session Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Treatment of pulmonary NTM infection: can it be done? Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007 Efficacy and safety of bronchial artery embolization for the control of hemoptysis in patients with mycobacterium avium complex lung disease Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease Source: Eur Respir J 2016; 48: 928-931 Year: 2016 Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015